- $1.82m
- $12.17m
- $81.19m
- 40
- 83
- 19
- 44
Annual income statement for Omniq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 57.2 | 55.2 | 78.3 | 103 | 81.2 |
Cost of Revenue | |||||
Gross Profit | 14 | 10.9 | 16.7 | 22.1 | 15.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 60.1 | 64.2 | 88.7 | 112 | 107 |
Operating Profit | -2.86 | -8.98 | -10.5 | -9.55 | -26.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.44 | -11.5 | -13 | -13.6 | -30.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.46 | -11.5 | -13.1 | -13.6 | -29.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.46 | -11.5 | -13.4 | -13.7 | -29.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.31 | -11.3 | -13.4 | -13.9 | -29.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.37 | -2.62 | -2.21 | -1.83 | -2.37 |